Sellas Life Sciences Group Inc (SLS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.52B
Last updated: Nov 17, 2026 at 4:44 PM ET
Sellas Life Sciences Group Inc (SLS) Stock Chart
Sellas Life Sciences Group (SLS) has a latest price of $19.15 on Nov 17, 2026. Its price rose 1,239.2% over the past 12 months. The month-end price fell 97.5% since Dec 2017, a compound annual decline of 34.2%.
Price Chart
From Dec 2017 to Oct 2026, its highest month-end close was $390.39 in Dec 2017 and its lowest $0.64 in Jan 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart SLS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SLS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 38.3%, and over 6 months it rose 152.3%. The month-end price rose 897.8% over the 3 years through Oct 2026, a compound annual rate of 115.3%.
| Period | Change |
|---|---|
| 1 month | +82.6% |
| 3 months | +38.3% |
| 6 months | +152.3% |
| 12 months | +1,239.2% |
| 12 months, with dividends | +1,239.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +897.8% | +115.3% |
| 5 years | +11.4% | +2.2% |
| Since Dec 2017 | -97.5% | -34.2% |
Price by Year
Its best calendar year was 2025, when the price rose 262.5%, and its weakest was 2019, when it fell 93.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $9.68 | +156.8% |
| 2025 | $3.77 | +262.5% |
| 2024 | $1.04 | -1.9% |
| 2023 | $1.06 | -55.1% |
| 2022 | $2.36 | -57.3% |
| 2021 | $5.53 | -4.8% |
| 2020 | $5.81 | +35.1% |
| 2019 | $4.30 | -93.0% |
| 2018 | $61.50 | -84.2% |
Trading Range
The price is 74.0% above its 50-day average of $11.01 and 115.7% above its 200-day average of $8.88.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $19.15 | |
| 50-day average | $11.01 | +74.0% |
| 200-day average | $8.88 | +115.7% |
Price Risk
Over 3 years, its largest fall from a peak was 58.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.76 |
| Largest fall, 1 year | -51.7% |
| Largest fall, 3 years | -58.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About SLS
What is SLS's 1-year price change?
Sellas Life Sciences Group's price rose 1,239.2% over the past 12 months. With dividends included, the 12-month total return was 1,239.2%.
What is SLS's 5-year price change?
Sellas Life Sciences Group's month-end price rose 11.4% over the 5 years through Oct 2026, a compound annual rate of 2.2%. These figures leave out dividends.
What is SLS's beta?
Sellas Life Sciences Group's 1-year beta against the S&P 500 is 1.76, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 51.7%.
Is the SLS chart free?
Yes. Advanced Charting for SLS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
SLS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors